FMR LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$362,748
-63.0%
31,031
-57.4%
0.00%
Q2 2023$979,288
+86.4%
72,864
+129.9%
0.00%
Q1 2023$525,430
+81.7%
31,690
+103.9%
0.00%
Q4 2022$289,116
-46.9%
15,544
-63.4%
0.00%
Q3 2022$544,000
+1713.3%
42,449
+906.4%
0.00%
Q2 2022$30,000
+7.1%
4,218
+24.2%
0.00%
Q1 2022$28,000
+100.0%
3,396
+68.2%
0.00%
Q4 2021$14,000
+16.7%
2,019
-16.5%
0.00%
Q3 2021$12,000
+71.4%
2,419
+109.8%
0.00%
Q2 2021$7,000
-12.5%
1,153
-35.9%
0.00%
Q1 2021$8,000
+33.3%
1,8000.0%0.00%
Q4 2020$6,000
+20.0%
1,8000.0%0.00%
Q3 2020$5,000
+25.0%
1,800
+150.7%
0.00%
Q2 2020$4,000
+300.0%
718
+402.1%
0.00%
Q1 2020$1,0000.0%143
-29.6%
0.00%
Q4 2019$1,0000.0%2030.0%0.00%
Q3 2019$1,000
-50.0%
203
-62.8%
0.00%
Q2 2019$2,000
-99.8%
546
-99.8%
0.00%
Q4 2017$1,173,000
+55.2%
300,0000.0%0.00%
Q3 2017$756,000
-8.7%
300,0000.0%0.00%
Q2 2017$828,000300,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders